Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
265 Leser
Artikel bewerten:
(1)

Aily Labs Expands Global Footprint with New York Office Launch and Strengthens Leadership Team with New SVP of Sales and Head of Marketing

Finanznachrichten News
  • Aily Labs opens a new office in New York City, enhancing its global presence alongside existing hubs in Munich, Madrid, Barcelona and Romania
  • New hires Jason Rizzo as Senior Vice President of Sales and Ken Huang as Head of Marketing bolster Aily Labs' global go-to-market and expansion, fortifying a team of more than 330 professionals dedicated to advancing AI innovation
  • This expansion and new leadership underscore Aily Labs' commitment to driving forward-thinking AI Decision Intelligence solutions and expanding worldwide market reach

MUNICH, July 31, 2024 /PRNewswire/ -- Aily Labs GmbH, pioneer of an AI-powered decision intelligence app for global enterprises, announced today its U.S. expansion with the opening of a new office at 66 Hudson Boulevard (The Spiral) in Manhattan's Hudson Yards. This strategic move is complemented by the appointment of two key leaders: Jason Rizzo as Senior Vice President of Sales and Ken Huang as Head of Marketing. These developments mark significant milestones in Aily Labs' strategy to scale its innovative AI solutions and amplify its impact on enterprise decision-making worldwide. Alongside the new New York office, Aily Labs maintains a robust European presence with its headquarters in Munich and additional hubs in Madrid, Barcelona, and Cluj.

Aily Labs Logo

"The New York expansion and our strategic hires are pivotal to accelerating Aily Labs' mission to democratize AI Decision Intelligence across industries," said Bianca Anghelina, CEO and Founder of Aily Labs. "We are committed to driving global impact through our advanced AI solutions."

Jason Rizzo, joining as Senior Vice President of Sales, brings over 20 years of experience in B2B cloud software. With a proven track record in complex sales landscapes and strategic partnerships, Rizzo will be instrumental in expanding Aily Labs' global market reach and driving business growth. Previously, Rizzo served as Vice President of Global Life Science Strategy & Partnerships for InsightRX and led R&D and Quality for Veeva Systems.

Ken Huang, joining as Head of Marketing, brings extensive global B2B go-to-market expertise. Huang previously led global product marketing for Prove, a leader in identity verification and authentication. His experience in overseeing marketing efforts across end-to-end product portfolios and leading global expansion efforts across Europe, Asia-Pacific, and the Americas will be crucial in Aily Labs' global scaling.

"The addition of top-tier talent with Jason Rizzo and Ken Huang underscores Aily Labs' strategic approach to advancing AI innovation and scaling their technology's impact globally," said Hilary Gosher, Managing Director at Insight Partners, investor in Aily Labs.

The expansion in New York will supercharge Aily Labs' customer growth, enabling enhanced service to Fortune 500 clients across industries such as life sciences, fast-moving consumer goods, and retail services, and more. This strategic move builds on the momentum of recent product rollouts, including the innovative Aily Agent, further solidifying the company's position as a leader in AI-driven solutions.

About Aily Labs
Aily Labs transforms business needs into applied AI use cases, embedding them into an easy to-integrate and simple-to-use app. Founded in 2020, Aily Labs is an AI Software (or AI SaaS) company and is on a mission to transform ways of working by empowering businesses with meaningful AI. Aily Labs accelerates the digital journeys of large, global organizations, supported by an experienced team of digital specialists and data scientists. For more information, visit ailylabs.com.

Aily Labs Contact
Ken Huang
Ken.Huang@AilyLabs.com

Jessica Muldoon
AilyLabs@ruderfinn.com

Logo - https://mma.prnewswire.com/media/2417466/Aily_Labs_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/aily-labs-expands-global-footprint-with-new-york-office-launch-and-strengthens-leadership-team-with-new-svp-of-sales-and-head-of-marketing-302210472.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.